Drawing for CERECIN

USPTO serial 88131027

CERECIN

Reviewed by CopyMark Law Group

Reg. 6148167Status 700Renewal
Filing date
Status date
Registration date
Sep 8, 2020
Examiner
HUDSON, TAMARA BREE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CERECIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rhiannon D'Agostin

Rhiannon D'Agostin Norton Rose Fulbright US LLP1225 Seventeenth Street, Suite 3050Denver, CO 80202United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treatment of neurodegenerative diseases and metabolic diseases; Dietary and nutritional additives in the nature of nutritional supplements for medical purposes; Dietetic foods and beverages adapted for medical use; Dietetic foods and beverages adapted for medical purposes; Homogenized food adapted for medical purposes; Preparations for pharmaceutical or medical purposes, namely, for treatment of neurodegenerative diseases and metabolic diseasesACTIVEJan 6, 2020
042Scientific consulting and research services relating to neurodegenerative disease, metabolic diseases, metabolic treatments, and foods and dietary supplements; Pharmaceutical research and development; Medical and scientific research in the field of neurodegenerative diseases, metabolic diseases, metabolic treatments and foods and dietary supplements; Medical research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the field of neurodegenerative diseases, metabolic diseases, metabolic treatments and foods and dietary supplementsACTIVEOct 7, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 8, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 2, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 2, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 2, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 6, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 5, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 23, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 23, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 23, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 17, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 17, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 26, 2020IUAFUSE AMENDMENT FILED—
Jun 26, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 26, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 26, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 26, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 26, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 26, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 26, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 4, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 2, 2020EX1GSOU EXTENSION 1 GRANTED—
Jan 2, 2020EXT1SOU EXTENSION 1 FILED—
Jan 2, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 5, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 7, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 31, 2019ALIEASSIGNED TO LIE—
Mar 12, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 8, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 11, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 11, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 11, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2019DOCKASSIGNED TO EXAMINER—
Oct 2, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 28, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance